Clinical trials
Phase 3 Cachexia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2015 | 1 |
| 2019 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 3 |
| Helsinn Therapeutics (U.S.), Inc | 3 |
| Helsinn Healthcare SA | 2 |
| Par Pharmaceutical, Inc. | 2 |
| Wake Forest University Health Sciences | 2 |
| Bristol-Myers Squibb | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| Norwegian University of Science and Technology | 1 |
| Radiation Therapy Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cachexia | 18 |
| Anorexia | 10 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Neoplasms | 5 |
| Lung Neoplasms | 4 |
| Body Weight | 3 |
| Weight Loss | 3 |
| Body Weight Changes | 2 |
| Lymphoma, Large-Cell, Anaplastic | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.